Marinus Pharmaceuticals (MRNS) Stock Highlights

0.3 | -82.25%

2024-10-25 05:04:19

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.

Statistics

Range Today

0.28 0.52

Volume Today 47.96M

Range 1 Year

1.05 11.26

Volume 1 Year 241.37M

Range 3 Year

1.05 13.15

Volume 3 Year 460.3M

Range 10 Year

1.05 82.88

Volume 10 Year 922.04M

Highlights

Market Capitalization 101.91M (small)

Floating Shares 42.88M

Current Price 0.3

Price To Earnings -0.65

Price To Revenue 4.4

Earnings Per Share -2.66

Payout Ratio 0%

Performance

Latest -82.25%

1 Month -81.71%

3 Months -79.59%

6 Months -79.17%

1 Year -95.43%

3 Years -97.29%

5 Years -94.05%

10 Years -98.8%

Benchmarks

Market Capitalization

165 / 368

Gross Profits

202 / 278

Total Revenue

143 / 300

Total Rank

191 / 368

Free Cashflow

259 / 352

Performance 5 years

210 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.